Maverick Capital’s Pediatrix Medical MD Stock Holding History

Maverick Capital’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-32,688	Closed	-$487K	–	496
2023 Q1	$487K	Buy	+32,688	New	+$495K	0.01%	273
2022 Q1	–	Sell	-5,051	Closed	-$137K	–	315
2021 Q4	$137K	Sell	5,051 -30,161	-86%	-$807K	﹤0.01%	117
2021 Q3	$1M	Buy	35,212 +3,054	+9%	+$93.1K	0.01%	315
2021 Q2	$970K	Buy	+32,158	New	+$949K	0.01%	306
2021 Q1	–	Sell	-16,742	Closed	-$411K	–	805
2020 Q4	$411K	Sell	16,742 -100,664	-86%	-$1.89M	0.01%	394
2020 Q3	$1.91M	Buy	117,406 +34,445	+42%	+$641K	0.04%	148
2020 Q2	$1.42M	Sell	82,961 -33,545	-29%	-$497K	0.03%	231
2020 Q1	$1.36M	Buy	+116,506	New	+$2.4M	0.03%	247

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Maverick Capital's MD Position: Q2 2023 in Review

Maverick Capital sold out of Pediatrix Medical (MD) in Q2 2023, closing a stake of 32,688 shares — an estimated $487K sold.

Maverick Capital first reported a position in MD in Q1 2020 and held it in 8 quarters. The position peaked at $1.91M in Q3 2020. 215 funds tracked by Wall St. Rank hold MD as of Q2 2023.

Maverick Capital reported no remaining Pediatrix Medical position as of Q2 2023 after selling out during the quarter.
Maverick Capital sold 32,688 Pediatrix Medical shares in Q2 2023, an estimated $487K.
Maverick Capital first reported a position in Pediatrix Medical in Q1 2020 and held it in 8 quarters.
Maverick Capital's Pediatrix Medical position peaked at $1.91M in Q3 2020.
215 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2023.

Based on Maverick Capital's 13F filing for Q2 2023, filed 14 Aug 2023.